RECKITTBEN Stock Overview
Manufactures and markets household, toiletry, and pharmaceutical products in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Reckitt Benckiser (Bangladesh) PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳4,404.60 |
| 52 Week High | ৳5,271.00 |
| 52 Week Low | ৳3,799.00 |
| Beta | 0.16 |
| 11 Month Change | -2.61% |
| 3 Month Change | -9.39% |
| 1 Year Change | -7.48% |
| 33 Year Change | -11.29% |
| 5 Year Change | 57.00% |
| Change since IPO | 1,987.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| RECKITTBEN | BD Household Products | BD Market | |
|---|---|---|---|
| 7D | -4.9% | -1.9% | -1.0% |
| 1Y | -7.5% | -11.5% | -20.0% |
Return vs Industry: RECKITTBEN exceeded the BD Household Products industry which returned -11.5% over the past year.
Return vs Market: RECKITTBEN exceeded the BD Market which returned -20% over the past year.
Price Volatility
| RECKITTBEN volatility | |
|---|---|
| RECKITTBEN Average Weekly Movement | 2.8% |
| Household Products Industry Average Movement | 5.2% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in BD Market | 9.4% |
| 10% least volatile stocks in BD Market | 3.9% |
Stable Share Price: RECKITTBEN has not had significant price volatility in the past 3 months compared to the BD market.
Volatility Over Time: RECKITTBEN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1938 | 286 | Vishal Gupta | reckitt.com |
Reckitt Benckiser (Bangladesh) PLC manufactures and markets household, toiletry, and pharmaceutical products in Bangladesh. The company sells its hygiene, health, and nutrition products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, Woolite, Airborne, Biofreeze, Clearasil, Dettol, Durex, Gaviscon, K-Y, Move Free, Mucinex, Neuriva, Nurofen, Strepsils, Veet, Enfamil, and Nutramigen brands. The company was formerly known as Reckitt & Colman Bangladesh Limited and changed its name to Reckitt Benckiser (Bangladesh) PLC in November 2000.
Reckitt Benckiser (Bangladesh) PLC Fundamentals Summary
| RECKITTBEN fundamental statistics | |
|---|---|
| Market cap | ৳20.81b |
| Earnings (TTM) | ৳794.64m |
| Revenue (TTM) | ৳5.25b |
26.2x
P/E Ratio4.0x
P/S RatioIs RECKITTBEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RECKITTBEN income statement (TTM) | |
|---|---|
| Revenue | ৳5.25b |
| Cost of Revenue | ৳2.67b |
| Gross Profit | ৳2.58b |
| Other Expenses | ৳1.78b |
| Earnings | ৳794.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 168.18 |
| Gross Margin | 49.11% |
| Net Profit Margin | 15.14% |
| Debt/Equity Ratio | 23.2% |
How did RECKITTBEN perform over the long term?
See historical performance and comparison